F. Canbolat Et Al. , "Quantitation of escitalopram and its metabolites by liquid chromatography-tandem mass spectrometry in psychiatric patients: New metabolic ratio establishment," Basic and Clinical Pharmacology and Toxicology , vol.124, no.3, pp.285-297, 2019
Canbolat, F. Et Al. 2019. Quantitation of escitalopram and its metabolites by liquid chromatography-tandem mass spectrometry in psychiatric patients: New metabolic ratio establishment. Basic and Clinical Pharmacology and Toxicology , vol.124, no.3 , 285-297.
Canbolat, F., Tasdemir Erinç, D. M., Evrensel, A., Aydın, A., & Tarhan, K. N., (2019). Quantitation of escitalopram and its metabolites by liquid chromatography-tandem mass spectrometry in psychiatric patients: New metabolic ratio establishment. Basic and Clinical Pharmacology and Toxicology , vol.124, no.3, 285-297.
Canbolat, FADİME Et Al. "Quantitation of escitalopram and its metabolites by liquid chromatography-tandem mass spectrometry in psychiatric patients: New metabolic ratio establishment," Basic and Clinical Pharmacology and Toxicology , vol.124, no.3, 285-297, 2019
Canbolat, FADİME Et Al. "Quantitation of escitalopram and its metabolites by liquid chromatography-tandem mass spectrometry in psychiatric patients: New metabolic ratio establishment." Basic and Clinical Pharmacology and Toxicology , vol.124, no.3, pp.285-297, 2019
Canbolat, F. Et Al. (2019) . "Quantitation of escitalopram and its metabolites by liquid chromatography-tandem mass spectrometry in psychiatric patients: New metabolic ratio establishment." Basic and Clinical Pharmacology and Toxicology , vol.124, no.3, pp.285-297.
@article{article, author={FADİME CANBOLAT Et Al. }, title={Quantitation of escitalopram and its metabolites by liquid chromatography-tandem mass spectrometry in psychiatric patients: New metabolic ratio establishment}, journal={Basic and Clinical Pharmacology and Toxicology}, year=2019, pages={285-297} }